Loading patent…
AssigneesJapanese Foundation for Cancer Research, Osaka University, Tosoh Corporation
InventorsKoji UEDA, Naomi OHNISHI, Kazutake TSUJIKAWA, Norio NONOMURA, Motohide UEMURA, Kentaro JINGUSHI, Norihisa OHTAKE, Yasutoshi KAWAI
Estimating the term…
An object of the invention is to provide a method for detecting cancer in a simple and highly accurate manner, and a reagent that can be used in the method. A method for detecting cancer (excluding renal cell cancer), which comprises measuring the level of Azurocidin (AZU1) in a sample, in which it is determined that cancer is detected when a measured value exceeds a preset reference value. The cancer is preferably selected from the group consisting of stomach cancer, breast cancer, colorectal cancer, and lung cancer. A reagent containing an antibody that specifically recognizes AZU1 is used in detecting cancer (excluding renal cell cancer).
A method for detecting cancer (excluding renal cell cancer), which comprises measuring a level of Azurocidin (AZU1) in a sample,
A reagent for use in detecting cancer (excluding renal cell cancer), which contains an antibody that specifically recognizes AZU1 and an antibody or receptor that specifically recognizes any of second markers listed in Table 2.
(canceled)
The reagent according to claim 97, wherein the second marker contains at least one of CD81, CD63, CD9, and phosphatidylserine.
A method for treating cancer (excluding renal cell cancer) in a patient, which comprises:
Dependencies are inferred from the claim text.